advanced search

Welcome: Guest

log in

ICD-10: The Final Healthcare Market Change Agent?

Publication Date March 2009
Publisher IDC
Product Type Report
Pages 8
ISBN Number not applicable
Product Code IDC07243
Buy this product or for assistance call +44 20 7060 7474

Summary

This Health Industry Insights report assesses healthcare payer and vendor ICD-10 remediation plans, challenges, and solution strategies. Also presented are new business and technology scenarios likely to emerge from the combines stresses of ICD-10, the aging U.S. population, additional federal and technology mandates, and the economic slowdown. In February 2009, the Department of Health and Human Service finalized and set the long-awaited ICD-10 compliance date for October 1, 2013. ICD-10 remediation during a time of rapid business and economic changes will present challenges to the healthcare industry equal to HIPAA or Y2K.

"HII's early assessment of ICD-10 implications suggests that the regulation has the potential to be as much a market disruptor as a solution to a limited and antiquated coding scheme for reporting, cost management, and more targeted care management programs. Healthcare payers must view ICD-10 as a strategic disruptor and manage ICD-10 remediation to reassess business and technology strategies and future differentiation models," says Janice Young, Health Industry Insights program manager for Healthcare Payer Research.

Content

  • Health Industry Insights Opinion
  • In This Report
    • Brief Description of the Solution
  • Situation Overview
  • Future Outlook
    • Remaining Challenges
      • Ramping Up
      • Vendor Management
    • Future Adoption Patterns
      • ICD-10 Affect on Healthcare Payer Application Platform Management
      • ICD-10 Affect on Application and Software Vendors
        • Coordination with External Vendors
      • ICD-10 as Strategic Change Agent
    • Potential Pitfalls
      • Crosswalk Solutions
      • Integration and Data Management Disconnects
      • Loss of Transparency
  • Essential Guidance
    • Actions to Consider
      • Healthcare Payers
      • Software and Applications Vendors
  • Learn More
    • Related Research
    • Synopsis

Industry Events

Oncology Market & Patient Access

14 Dec 09 to 16 Dec 09
Prague, Czech Republic
view summary >>

Orphan & Ultra Orphan Drugs

13 Jan 10 to 14 Jan 10
Brussels, Belgium
view summary >>

2nd International Conference on Drug Discovery and Therapy

01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>